Lundbeck
Beth Wolff is an accomplished professional in the fields of digital health and commercial excellence, currently serving as an Advisory Board Member at Afya Intelligence and as the Director of AI and Digital Health Solutions Lead at Lundbeck. With a robust background, Wolff has held senior roles at notable companies such as Brain+, where the role of Chief Commercial Officer involved securing partnerships for dementia treatments; Sandoz, focusing on Commercial Excellence in the Nordics; and LEO Pharma, where leadership in patient insights aimed at enhancing product development. Educational qualifications include a Master's in Public Health from the London School of Hygiene and Tropical Medicine, an MA in Political Economy from the University of Essex, and a BA with Full Honors in Political Science from the University of Wisconsin-Madison.
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.